Key Takeaways
- • Brummer Multi-Strategy posted a 4.06% gain in October 2025, bringing year-to-date performance to +10.74%, though this trails the MSCI World's +17.52% YTD return.
- • Long/short equity strategies drove October outperformance with a +4.20% contribution, demonstrating resilience amid broader market headwinds, while systematic trend-following added +0.80% and systematic macro detracted marginally at -0.02%.
- • Brummer & Partners manages over $10 billion in assets across its Stockholm-based multi-strategy platform, which combines long/short equity (62% allocation), systematic trend-following (25%), and systematic macro strategies.
- • The multi-strategy fund's three-pronged approach continues to generate consistent monthly gains throughout 2025, supported by dispersion opportunities in equity markets, particularly within healthcare and technology sectors.
Summary
Brummer Multi-Strategy, the flagship fund from Stockholm-based Brummer & Partners, delivered a 4.06% return in October 2025, extending its year-to-date performance to +10.74%. Despite solid monthly execution, the fund remains approximately 680 basis points behind the MSCI World Index, which has posted +17.52% through the same period. The fund's underperformance relative to global equities reflects the inherent diversification trade-offs embedded in its multi-strategy architecture, which prioritizes risk mitigation alongside capital appreciation.
The October performance breakdown reveals the fund's strategic composition and the uneven contribution across its three primary components. Long/short equity contributed +4.20% to returns, emerging as the primary performance driver and successfully navigating volatile market conditions. Systematic trend-following strategies added a more modest +0.80%, while systematic macro exposures detracted -0.02%, resulting in a net positive monthly outcome. This segmented performance underscores the current market environment's favorability toward equity market-neutral strategies, particularly those with concentrated exposure to dispersion-driven opportunities.
Brummer & Partners, founded in 1996 by Patrick Brummer, operates as a European multi-strategy hedge fund house with over $10 billion in assets under management. The Brummer Multi-Strategy vehicle's architecture allocates approximately 62% to long/short equity strategies, 25% to systematic trend-following, with the remainder deployed to systematic macro strategies. The consistent positive monthly returns throughout 2025 have been supported by strong performance from market-neutral positioning, particularly within healthcare and technology sectors where stock-specific dispersion has provided fertile ground for alpha generation.
The fund's October results align with broader trends across multi-strategy platforms in 2025, as dispersion and tactical flexibility have increasingly differentiated performance within a market environment characterized by concentration risk and elevated volatility. Long/short equity managers with disciplined exposure management and sector-specific conviction have capitalized on uneven sector rotation, particularly in technology and healthcare equities.
The October performance breakdown reveals the fund's strategic composition and the uneven contribution across its three primary components. Long/short equity contributed +4.20% to returns, emerging as the primary performance driver and successfully navigating volatile market conditions. Systematic trend-following strategies added a more modest +0.80%, while systematic macro exposures detracted -0.02%, resulting in a net positive monthly outcome. This segmented performance underscores the current market environment's favorability toward equity market-neutral strategies, particularly those with concentrated exposure to dispersion-driven opportunities.
Brummer & Partners, founded in 1996 by Patrick Brummer, operates as a European multi-strategy hedge fund house with over $10 billion in assets under management. The Brummer Multi-Strategy vehicle's architecture allocates approximately 62% to long/short equity strategies, 25% to systematic trend-following, with the remainder deployed to systematic macro strategies. The consistent positive monthly returns throughout 2025 have been supported by strong performance from market-neutral positioning, particularly within healthcare and technology sectors where stock-specific dispersion has provided fertile ground for alpha generation.
The fund's October results align with broader trends across multi-strategy platforms in 2025, as dispersion and tactical flexibility have increasingly differentiated performance within a market environment characterized by concentration risk and elevated volatility. Long/short equity managers with disciplined exposure management and sector-specific conviction have capitalized on uneven sector rotation, particularly in technology and healthcare equities.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.